“Customized Treatment for Disabling Blepharospasm or Apraxia of Eyelid Opening in Parkinson Disease Patients After Deep Brain Stimulation”

https://pubmed.ncbi.nlm.nih.gov/38117577

Patients with Parkinson disease who develop disabling blepharospasm or apraxia of eyelid opening after deep brain stimulation of the subthalamic nucleus can achieve measurable symptom improvement through a customized treatment approach involving both botulinum toxin injections and surgery.